Preview

Системные гипертензии

Расширенный поиск

Современные представления о взаимосвязи ожирения и эректильной дисфункции у больных артериальной гипертонией

Аннотация

В данной статье рассмотрены основные современные понятия ожирения, а также даны определение, степени тяжести, распространенность и его патогенетические особенности. Представлены различные методы диагностики ожирения, включающие лабораторную диагностику и визуализирующие методы. Рассмотрена роль биомаркеров жировой ткани в диагностике ожирения. Подробно описаны преимущества и недостатки различных визуализирующих методов диагностики ожирения. Также в статье описаны эпидемиология, этиология и патогенез эректильной дисфункции, рассмотрены диагностические возможности в зависимости от этиологических факторов данной патологии. Подробно приведена взаимосвязь эректильной дисфункции с ожирением у больных артериальной гипертонией. В обзоре в том числе рассмотрен каскад гормональных и метаболических нарушений, приводящих к формированию порочного круга у больных с ожирением и эректильной дисфункцией. Приведены данные результатов как международных, так и отечественных исследований. В заключение эректильная дисфункция представлена как независимый предиктор сердечно-сосудистых катастроф.

Об авторах

Татьяна Анатольевна Алексеева
ФГБУ «НМИЦ кардиологии»
Россия


Александр Юрьевич Литвин
ФГБУ «НМИЦ кардиологии»
Россия


Список литературы

1. Клинические рекомендации, разработанные экспертами РМОАГ, по диагностике и лечению артериальной гипертонии, 2013

2. Литвин А.Ю., Чазова И.Е. Синдром обструктивного апноэ во время сна: механизмы развития, клиническое значение, связь с сердечно-сосудистыми заболеваниями, принципы лечения. Кардиологический вестн. 2009; 4 (2): 89-103

3. Roth A, Kalter-Leibovici O, Kerbis Y. et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1412 Israeli men. Clin Cardiol 2003; 26 (1): 25-30.

4. Kirby M, Jackson G, Betteridge J, Friedli K. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001; 55 (9): 614-8.

5. Harman S.M, Metter E.J, Tobin J.D et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-31.

6. Mokdad A.H. et al. Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001.

7. Colten H.R et al. A study of the link between partial sleep deprivation and obesity. Honors College Theses 2001; Paper 112.

8. Xu H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112 (12): 1821-30.

9. Hotta K. et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50 (5): 1126-33.

10. Kyle T.K, Dhurandhar E.J, Allison D.B. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am 2016; 45: 511-20.

11. Allison D.B, Downey M, Atkinson R.L. et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) 2008; 16: 1161-77.

12. Kuczmarski R.J. What is obesity? Definitions matter. In: Kumanyika S, Brownson RC, eds. Handbook of Obesity Prevention: A Resource for Health Professionals. New York, NY: Springer; 2007: p. 25-44.

13. Kragelund C, Omland T. A farewell to body-mass index? Lancet 2005; 366: 1589-91.

14. Romero-Corral A, Somers V.K, Sierra-Johnson J et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008; 32: 959-66.

15. Burwell C.S, Robin E.D, Whaley R.D, Bicklemann AG. Extreme obesity associated with alveolar hypoventilation; a Pickwickian syndrome. Am J Med 1956; 21 (5): 811-8. DOI: 10.1016/0002-9343(56)90094-8

16. Schneider H.J, Glaesmer H, Klotsche J. et al. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab 2007; 92: 589-94.

17. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012; 13: 275-86.

18. Ho-Pham L.T, Campbell L.V, Nguyen T.V. More on body fat cutoff points. Mayo Clin Proc 2011; 86: 584-5.

19. Snitker S, Lavie C.J, Milani R.V. Use of body fatness cutoff points. Mayo Clin Proc 2010; 85: 1057-8.

20. Bull World Health Organ 2013; 91: 549-50. http://dx.doi.org/10.2471/BLT.13.020813

21. Ogden C.L et al. Prevalence of Childhood and Adult Obesity in the United States. JAMA 2014.

22. Ettehad D, Emdin C.A, Kiran A.et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2015; published online Dec 23. http://dx.doi.org/10.1016/ S0140-6736(15)01225-8

23. Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно-сосудистых заболеваний в Российской популяции больных артериальной гипертензией. Кардиология. 2014; 10. http://dx.doi.org/10.18565/cardio.2014.10.4-

24. The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377: 13-27. DOI: 10. 1056/NEJMoa1614362

25. Irlbeck T, Massaro J.M, Bamberg F. et al. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study. Int J Obes (Lond) 2010; 34 (4): 781-7.

26. Fernando F, Ribeiro-Filho, Alessandra N et al. Methods of Estimation of Visceral Fat: Advantages of Ultrasonography First published: December 2003. DOI: 10.1038/oby.2003.199

27. Klopfenstein B.J, Kim M.S, Krisky C.M. et al. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans Br J Radiol 2012; 85 (1018): e826-e830. DOI: 10.1259/bjr/57987644

28. Després J.P, Moorjani S, Lupien P.J. et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990; 10: 497-511.

29. Messier V, Karelis A.D, Prud'homme D. et al. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 2010; 18: 911-7.

30. Wildman R.P, Muntner P, Reynolds K. et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-24.

31. Haiyan Xu, Glenn Barnes T, Qing Yang et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulinresistance. 2003 Published December 15, 2003 Citation Information: J Clin Invest 2003; 112 (12): 1821-30. DOI:10.1172/JCI19451

32. Kikuko Hotta, Tohru Funahashi, Noni Bodkin L et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50 (5): 1126-33. https://doi.org/10.2337/diabetes.50.5.1126

33. Wei-Shiung Yang, Wei-Jei Lee, Tohru Funahashi et al. Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin J Clin Endocrinol Metab 2002; 87 (4): 1626.

34. Gema Frühbeck Intracellular signalling pathways activated by leptin. Biochemic J 2006; 393 (1): 7-20. DOI: 10.1042/BJ20051578

35. Henry Feldman A, Irwin Goldstein, Dimitrios Hatzichristou G et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urology 1994; 151: 54-61.

36. Laumann E.O, Paik A, Rosen R.C. Sexual Dysfunction in the United States: Prevalence and Predictors. J Am Med Associat 1999; 281: 537-44. http://dx.doi.org/10.1001/jama.281.6.537

37. Budweiser S, Enderlein S, Jörres R.A. et al. Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med 2009; 6 (11): 3147-57. Epub 2009 Jun 29.

38. Pittaras F et al. Erectile Dysfunction in Hypertension and Cardiovascular Disease. Guid Clin J Hypertens 2011; 29: 403-7.

39. Grunstein R.R, Handelsman D.J, Lawrence S.J. et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy J Clin Endocrinol Metab 1989; 68: 352-8.

40. Hatzimouratidis K (Chair), Giuliano F, Moncada I et al. EAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism European Association of Urology 2016.

41. Gratzke C.et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 2010; 7: 445.

42. Nehra A, Azadzoi K.M, Moreland R.B. et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 1998; 159: 2229.

43. Okabe H, Hale T.M, Kumon H. et al. The penis is not protected - in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res 1999; 11: 133.

44. Iacono F, Barra S, De Rosa G. et al. Microstructural disorders of tunica albuginea in patients affected by Peyronie’s disease with or without erection dysfunction. J Urol 1993; 150: 1806.

45. Sachs B, Meisel R.L. The physiology of male sexual behavior. In: The Physiology of Reproduction. Edited by E.Knobil, J.Neill, L.Ewing. New York: Raven Press, 1988; p. 1393-423.

46. Rosen R.C. et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.

47. Abdelrahman Elnashara Amr M, Gadallaha Alaa Abdelaala A. Can the International Index of Erectile Function (IIEF-5) be used as a diagnostic tool to the severity of vasculogenic erectile dysfunction? Middle East Fertil Soc J 2012; 17 (2): 101-4.

48. Kassouf W, Carrier S. A comparison of the International Index of Erectile Function and erectile dysfunction studies BJU Int 2003; 91 (7): 667-9.

49. Samir Elhanbly, Ayman Elkholy. Nocturnal Penile Erections. The Role of RigiScan in the Diagnosis of Vascular Erectile Dysfunction. First published: 11 October 2012. DOI: 10.1111/j.1743-6109.2012.02954.x

50. Пушкарь Д.Ю. Эректильная дисфункция - современные методы диагностики и лечения. Справочник поликлинического врача. 2004; 2.

51. Mokdad A.H. et al. Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001.

52. Colten H.R. et al. A study of the link between partial sleep deprivation and obesity. Honors College Theses 2001; Paper 112.

53. Silva Rebeca Cipriano Braga, Silva Diego Augusto da, Bastos João Luiz Dornelles et al. Anthropometric measures change and incidence of high blood pressure levels among adults: a population-based prospective study in Southern Brazil. J Hypertens 2017; 35 (1): 39-46.

54. Seven Ekima, Husemoen Lise L.N, Wachtell Kristiana et al. Five-year weight changes associate with blood pressure alterations independent of changes in serum insulin. J Hypertens 2014; 32 (11): 2231-7.

55. Беленков Ю.Н., Чазова И.Е., Мычка В.Б. Многоцентровое рандомизированное открытое исследование по изучению эффективности изменения образа жизни и терапии ингибитором АПФ (квинаприлом) у больных ожирением и артериальной гипертонией (ЭКО). Артер. гипертенз. 2003; 11 (6): 196-9

56. Young T. et al. Interactions Between Obesity and Obstructive Sleep Apnea. Chest 2010; 137 (3): 711-9.

57. Mortimore I.L, Marshall I, Wraith P.K et al. Neck and total body fat deposition in nonobese and obese patients withsleep apnea compared with that in control subjects. Am J Respir Crit Care Med 1998; 157: 280-3.

58. Davies R.J, Ali N.J, Stradling J.R. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47: 101-5.

59. Saini J, Krieger J, Bradenberger G. et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993; 25 (7): 375-81.

60. Lonn L, Johansson G, Sjostrom L. et al. Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment. Obes Res 1996; 4: 45-54.

61. Takahashi Y, Kipnis D.M, Daughaday W.H. Growth hormone secretion during sleep. J Clin Invest 1968; 47 (9): 2079-90. DOI: 10.1172/JCI105893

62. Van Cauter E, Copinschi G. Interrelationships between growth hormone and sleep. Growth Horm IGF Res 2000; 10: 57-62.

63. Esposito K, Giugliano F, Di Palo C. et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291 (23): 2978-84.

64. Schipilliti M, Caretta N, Palego P et al. Metabolic syndrome and erectile dysfunction: the ultrasound evaluation of cavernosal atherosclerosis. Diabetes Care 2011; 34 (8): 1875-7.

65. Roth A, Kalter-Leibovici O, Kerbis Y. et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1412 Israeli men. Clin Cardiol 2003; 26 (1): 25-30.

66. Mulvany M.J. Small artery remodeling in hypertension. Curr Hypertens Rep 2002; 4: 49.

67. Gundle M.J, Reeves B.R.Jr. et al. Psychosocial outcome after coronary artery surgery. Am J Psychiatry 1980; 137: 1591-4.

68. Wabrek A.J et al. Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980; 9: 69-77.

69. Jackson G, Betteridge J, Dean J. et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract 1999; 53: 445-1.

70. Montorsi P, Ravagnani P.M, Galli S.et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005; 96 (26): 19-23.

71. Jackson Gю et al. Presented at: 10th World Congress of the International Society for Sexual and Impotence Research; September 22-26, 2002; Montréal, Québec, Canada.

72. Hodges L.D, Kirby M, Solanki J. et al. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Prac. 2007; 61: 2019-25.

73. Inman B.A, St. Sauver J.L, Jacobson D.J et al. A population-based longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84 (2): 108-13.

74. Гамидов С.И., Тажетдинов О.Х., Павловичев А.А. и др. Особенности патогенеза, диагностики и лечения эректильной дисфункции у больных с гипогонадизмом. Проблемы эндокринол. 2010; 5: 33-42.

75. Tivesten A, Vandenput L, Labrie F et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metabol 2009.

76. Haring R, Völzke H, Steveling A et al. Low testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 2010; 31:1436-7.

77. Kay-Tee Khaw, Mitch Dowsett, Elizabeth Folkerd et al. Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men. European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. https://doi.org/10.1161/CIRCULATIONAHA.107.719005 Circulation. 2007; Originally published November 26, 2007.

78. Oh J.Y, Barrett-Connor E, Wedick N.M, Wingard D.L. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 2002; 25 (1). [PubMed]

79. Pasquali R, Macor C, Vicennati V.et al. Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. Metabolism 1997; 46 (5): 526-9. [PubMed]

80. Max Hirshkowitz, lsmet Karacan, Ahmet Gurakar, Robert Williams L. Hypertension, Erectile Dysfunction, and Occult Sleep Apnea. Raven Press, Ltd., New York. Sleep 1989; 12 (3): 223-2.


Рецензия

Для цитирования:


Алексеева Т.А., Литвин А.Ю. Современные представления о взаимосвязи ожирения и эректильной дисфункции у больных артериальной гипертонией. Системные гипертензии. 2017;14(4):38-43.

For citation:


Alekseeva T.A., Litvin A.Y. Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension. Systemic Hypertension. 2017;14(4):38-43.

Просмотров: 2


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)